Invention Grant
- Patent Title: EHV insertion site UL43
-
Application No.: US16980723Application Date: 2019-03-19
-
Publication No.: US11596681B2Publication Date: 2023-03-07
- Inventor: Alice Mundt , Andreas Gallei , Kristina Rehmet
- Applicant: Boehringer Ingelheim Vetmedica GmbH
- Applicant Address: DE Ingelheim am Rhein
- Assignee: Boehringer Ingelheim Vetmedica GmbH
- Current Assignee: Boehringer Ingelheim Vetmedica GmbH
- Current Assignee Address: DE Ingelheim am Rhein
- Agent Steffan Finnegan
- Priority: EP18162636 20180319
- International Application: PCT/EP2019/056749 WO 20190319
- International Announcement: WO2019/179966 WO 20190926
- Main IPC: A61K39/12
- IPC: A61K39/12 ; C12N15/86 ; A61K39/00
Abstract:
The present invention relates to the field of (vector) vaccines, and especially to the novel EHV insertion site UL43. The present invention further concerns related expression cassettes and vectors, which are suitable to express genes of interest, especially antigen encoding sequences. The viral vectors of the present invention are useful for producing an immunogenic composition or vaccine.
Public/Granted literature
- US20210100890A1 NEW EHV INSERTION SITE UL43 Public/Granted day:2021-04-08
Information query
